Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Perrigo’s Pivot To Building Brand Market Share Boosted With Opill OTC Oral Contraceptive Approval

Jul 13 2023

• By Malcolm Spicer

• Source: Shutterstock/FDA

Related Content

Omega Marks The Alpha Of Perrigo’s OTC Brand Play

Mar 19 2015

Perrigo’s First National Brand, Nasonex OTC Switch, Will Have Familiar Buzz In Advertising

Mar 21 2022

Perrigo Prioritizes Innovating First After Following OTC Brands To Market

Sep 10 2019

Room Available In US Pharma Industry For OTC Switch Leader: Has Perrigo Made A Reservation?

Sep 10 2021

Perrigo’s Next CEO Has Long OTC Brands History

Jun 08 2023

First OTC Birth Control Pill Approved In US Will Launch With Three-Year Market Exclusivity

Jul 13 2023

Related Companies

Perrigo Company PLC

GSK plc

Merck & Co., Inc.

Additional Topics

United States Business Strategies Prescription To OTC Switch Women's Health Advertising, Marketing & Sales Commercial Companies Consumer Drug Approval Standards Drug Review Ingredients Manufacturing OTC Drugs Policy Regulation Retail

More from Strategy

More from Business

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window